Skip to content Skip to footer
guy sitting on floor with questions

FAQ

General

The first step is to complete our intake process, which includes gathering your basic information, verifying your insurance, and filling out initial screening forms such as the PHQ-9, GAD-7, and PCL-5 to help us better understand your symptoms. You will then meet with one of our expert providers for a comprehensive psychiatric evaluation, where we will discuss your mental health history, symptoms, and treatment goals. 

Your initial intake appointment will last approximately 60 to 90 minutes, and follow-up visits are 30 minutes. For optimal outcomes, we typically meet weekly for the first month, biweekly for the following two months, and then transition to monthly maintenance visits.

We offer telehealth services to residents of Massachusetts and New Hampshire. In-person appointments are currently available for Spravato® (esketamine) treatments only at our Fitchburg, MA location and are by appointment.

Yes, we offer Saturday appointments from 8:00 AM to 12:00 PM, by appointment only.

MMHMPS is credentialed with a wide range of commercial insurance providers, including: Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare / Optum, Point32 / Harvard Pilgrim, Tufts (public/private), Commonwealth Care Alliance (CCA), WellSense, ComPsych and more.

In addition to medication management and psychiatric assessments, we offer:

  • Spravato® (esketamine) nasal spray treatment for treatment-resistant depression (available in Fitchburg)
  • ADHD evaluations and testing
  • Genetic testing to help guide medication decisions (pharmacogenetic testing)

We provide brief supportive therapy with medication management as part of psychiatric care. For patients who need regular weekly therapy, we often collaborate with outside therapists and can refer you to trusted providers.

Currently, we see patients aged 14 and older. For patients under 14, we are happy to refer you to a trusted child and adolescent provider.

Medication management refers to the process of evaluating, prescribing, monitoring, and adjusting psychiatric medications to treat mental health conditions. It involves a collaborative approach between you and your provider to ensure medications are working effectively and safely. The goal is to find the right medication, at the right dose, with the least side effects to support your overall mental health.

If you’re experiencing symptoms that interfere with your daily life, such as persistent sadness, anxiety, mood swings, sleep issues, or concentration problems, it may be time to consult with a provider. A comprehensive evaluation by a psychiatrist or nurse practitioner can help determine whether these symptoms are best addressed through medication, therapy, lifestyle changes, or a combination of treatments.

We treat a wide range of mental health conditions, including:

  • Depression (including treatment-resistant depression)
  • Anxiety disorders (Generalized Anxiety, Social Anxiety, Panic Attacks)
  • ADHD/ADD
  • PTSD and trauma-related symptoms
  • Mood disorders (including Bipolar Disorder)
  • OCD (Obsessive-Compulsive Disorder)
  • Insomnia and sleep-related issues
  • Substance Use Disorders
  • Grief and life transitions
  • Emotional disturbance and low self-esteem
  • Men’s issues (including erectile dysfunction related to mental health)
  • Women’s issues (including PMDD, prenatal and postpartum mood disorders)
  • Relationship stress, school-related or work-related stress

Our psychiatric providers are licensed to prescribe a wide range of psychotropic medications, including:

  • Antidepressants (SSRIs, SNRIs, NDRIs)
  • Anti-anxiety medications
  • Mood stabilizers
  • Antipsychotics
  • Sleep aids
  • Stimulants (for patients who have completed ADHD evaluation/testing)

To get started, simply call our office or send us an email on our website. We’ll review your information and contact you to schedule your initial appointment via Telehealth.

Spravato®

Spravato® is an FDA-approved nasal spray form of esketamine, a part of the ketamine molecule. Originally used as an anesthetic, esketamine has also been shown to help relieve depression symptoms, especially in people who haven’t responded to other treatments.

Yes. Spravato® was approved by the FDA on March 5, 2019 for depression treatment and it is covered by most insurance.

Spravato® is for adults with treatment-resistant depression (TRD) or major depressive disorder (MDD) with suicidal thoughts, especially if they have tried at least two antidepressants without success. Symptoms of MDD include low mood, low energy, poor sleep, appetite changes, hopelessness, and suicidal thoughts.

Spravato® and ketamine infusion are closely related, but they differ in important ways. Spravato® is the brand name for esketamine, which is a more refined version of ketamine, it uses only the S-enantiomer of the molecule, making it more targeted and effective at lower doses. Spravato® is FDA-approved specifically for treatment-resistant depression and depression with suicidal thoughts, while ketamine is only FDA-approved as an anesthetic and is used off-label for depression. Because of this, Spravato® must be administered in a certified clinic under a Risk Evaluation and Mitigation Strategy (REMS) program, meaning patients are monitored for at least two hours after each dose for safety. It is given as a nasal spray, whereas ketamine is usually given through an IV infusion or injection. Both medications act on the glutamate system in the brain, helping to rapidly reduce symptoms of depression by promoting new connections between brain cells (neuroplasticity). While both can be effective, Spravato® is generally covered by insurance, making it more accessible for many patients, whereas ketamine infusions are typically not covered and can be costly. Overall, Spravato® offers a more regulated, safer, and insurance-friendly option for patients who qualify.

Common side effects include feeling disconnected from yourself, your thoughts, feelings and things around you, dizziness, nausea, feeling sleepy, spinning sensation, decreased feeling of sensitivity (numbness), feeling anxious, lack of energy, increased blood pressure, vomiting, feeling drunk, headache, feeling very happy or excited. If these common side effects occur, they usually happen right after taking SPRAVATO® and go away the same day.

Do not drive, operate machinery, or do anything where you need to be completely alert after taking SPRAVATO®. Do not take part in these activities until the next day following a restful sleep.

You will start by completing an intake assessment with one of our advanced providers. We’ll review your medical and psychiatric history to determine if you meet clinical and insurance criteria. Most insurance plans require prior authorization before treatment can begin. Once approved, you will be able to begin Spravato® treatment.

Most start with twice-weekly treatments for 4 weeks, then once a week for 4 weeks. After that, maintenance treatments are usually every 2–4 weeks, based on individual needs and symptom control.

Spravato® is FDA-approved and administered nasally under medical supervision. IV ketamine is only used off-label through direct administration by a healthcare provider.

When covered by insurance, the cost is often similar to a regular mental health visit, sometimes as low as $10 per session. Final out-of-pocket costs depend on your plan and deductible.

ADHD Testing

Attention‑Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder characterized by persistent patterns of inattention, hyperactivity, and impulsivity that are developmentally inappropriate, interfere with daily functioning, and begin before age 12. ADHD often co-occurs with other conditions, such as anxiety, depression, or learning disorders.

According to the DSM‑5 criteria, symptoms must persist for at least six months and be present in two or more settings (e.g., home, school, work). Symptom groups include:

Inattention:

  • Often makes careless mistakes or overlooks details
  • Difficulty sustaining attention
  • Appears not to listen
  • Fails to follow through on instructions or tasks
  • Poor organization
  • Avoidance of tasks requiring sustained mental effort
  • Frequently loses necessary items
  • Easily distracted
  • Forgetfulness in daily activities

Hyperactivity‑Impulsivity:

  • Fidgets or squirms
  • Leaves seat often
  • Difficulty playing quietly
  • Talks excessively
  • Runs/climbs in inappropriate situations
  • Feels “driven by a motor”
  • Difficulty waiting turn
  • Blurts out answers
  • Interrupts or intrudes on others

“ADD” (Attention‑Deficit Disorder) is an outdated term that referred to inattentive-only ADHD. The current DSM‑5 recognizes three presentations of ADHD: predominantly inattentive, predominantly hyperactive-impulsive, and combined.

You may benefit from assessment if you consistently experience symptoms such as trouble focusing, impulsivity, disorganization, restlessness, or mood swings that affect daily functioning at home, school, or work. Our expert providers can evaluate your symptoms to determine if ADHD is present and distinguish it from other possible causes.

Untreated ADHD can lead to higher rates of anxiety, depression, and other mental health issues. It can negatively impact relationships, academic or work performance, and everyday routines, contributing to impulsivity, forgetfulness, frustration, poor time management, mood swings, and overall reduced quality of life.

We provide ADHD evaluations for individuals aged 14 and older.

Our evaluation is designed in phases to make it more cost-effective:

  1. Initial Diagnostic Evaluation & Pre‑assessment

    • During a 60 to 90 minute session, we assess psychiatric, medical, family, substance use, and trauma history, and rule out other conditions (e.g., anxiety, depression). We then send ADHD questionnaires via email to be completed before the next appointment.

  2. ADHD Assessment Session

    • We review questionnaire results, discuss your symptoms and challenges, and arrange for computerized ADHD testing to be done at home prior to the next visit.

  3. Computerized ADHD Test

    • You’ll complete the CNS Vital Signs™ test remotely via a secure portal. We’ll guide you with instructions. No software installation needed.

  4. Computer Testing Review & Treatment Planning

    • Your provider will analyze all data: interviews, questionnaires, test results, and discuss the findings, recommendations, and next steps (including EKG) in a follow-up session. Please allow 2–3 weeks for the full test report.

  5. Regular Follow‑Ups

    • Should medication be prescribed, we hold regular visits to monitor your symptoms and medication side effects.

No, everything is done virtually using secure, HIPAA-compliant tools. The at-home testing process is safe, secure, user-friendly, and efficient.

We utilize CNS Vital Signs™, a computerized, professionally-validated neurocognitive assessment tool. This platform evaluates domains such as memory, attention, processing speed, and reaction time to aid in an accurate ADHD diagnosis.

Treatment is tailored and typically includes:

  • Medication, often stimulants that enhance dopamine and norepinephrine activity
  • Behavioral strategies and psychoeducation, which may be recommended or coordinated with therapists for non-medication approaches

Yes! Our providers can prescribe appropriate medications following the evaluation and offer ongoing management, adjusting doses, monitoring side effects, and supporting your progress.

ADHD testing (e.g., questionnaires, CNS Vital Signs™) focuses on attention, impulsivity, and executive function. In contrast, neuropsychological testing is in-depth, often lasting multiple hours, and evaluates broader cognitive functions like memory, language, and visual-spatial skills, typically used when other learning or developmental concerns are present.

We bill in-network with most commercial insurers for ADHD testing and follow-up visits. Actual costs vary based on your specific insurance plan.

No. At My Mental Health Matters Psychiatric Services, we specialize exclusively in ADHD evaluation. A diagnosis of autism spectrum disorder (ASD) requires a comprehensive neurodevelopmental assessment conducted by trained specialists such as psychologists, neurologists, or developmental pediatricians. This often includes behavioral observation, social communication assessments, and standardized diagnostic tools like the ADOS-2 or ADI-R.

Similarly, diagnosing learning disorders (such as dyslexia or dyscalculia) involves psychoeducational testing typically conducted by a licensed psychologist or educational specialist. This includes academic achievement testing, IQ testing, and analysis of cognitive processing.

Genesight Testing

Medication genetic testing, also known as pharmacogenomic testing, helps determine how your body may respond to certain psychiatric medications based on your DNA. The GeneSight® Psychotropic test evaluates multiple genetic markers to predict how you may metabolize or react to medications commonly used to treat depression, anxiety, ADHD, and other conditions. This can reduce the trial-and-error process of finding the right medication and may also identify which medications could cause side effects or require dose adjustments. The test also factors in your smoking status, which can affect how you process certain medications.

We use the GeneSight® Psychotropic test, a clinically validated pharmacogenomic tool that analyzes your genetic makeup to help guide medication selection and dosing. It looks at how your genes may influence your response to medications for mental health conditions and helps your provider make more informed treatment decisions.

You may benefit from GeneSight testing if you:

  • Have had little or no improvement from past medications
  • Are experiencing side effects with your current medication
  • Want to better understand which medications may work best for you
  • Are beginning psychiatric treatment and want to avoid unnecessary medication trials

  • Provider Orders the Test: If your provider determines it’s appropriate, a GeneSight home collection kit will be mailed directly to your home.
  • Collect Your DNA Sample: Use the included cotton swabs to gently swab the inside of your cheek, quick, painless, and easy.
  • Send It Back: Place the sample in the prepaid FedEx envelope and send it to the GeneSight lab for analysis.
  • Results Are Processed: Once received, results are typically available within two business days.
  • Review With Your Provider: At your next appointment, your provider will go over the results and discuss what medications may be most effective and well-tolerated based on your genetics.

The GeneSight Psychotropic test analyzes two main categories of genes:

  • Pharmacokinetic genes, which influence how your body breaks down medications (e.g., CYP2D6, CYP2C19)
  • Pharmacodynamic genes, which affect how your body responds to medications (e.g., SLC6A4, HTR2A)

These insights help create a personalized medication plan based on your unique biology.

Each GeneSight home testing kit includes:

  • Two cotton-tipped swabs
  • DNA sample envelope
  • Patient consent form
  • Insurance and financial information forms
  • Prepaid return FedEx envelope
  • 98% of patients pay $330 or less
  • $0 out-of-pocket is typical for patients with Medicare Part B or Medicaid
  • GeneSight offers financial assistance and interest-free payment plans. If your cost could be more than $330, you’ll be contacted before processing the test so you can choose whether to proceed. Please visit their website for more information: https://genesight.com/cost/



Get the best blog stories
into your inbox!

Our site uses cookies. Learn more about our use of cookies: cookie policy